ArticleBMJ open2025
Gynaecological follow-up of adolescent and young adult cancer survivors: a comparative cohort study.
Article in BMJ open, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveTo assess whether gynaecological follow-ups among adolescent and young adult (AYA) cancer survivors are less compliant with recommendations than those without a history of AYA cancer.
designA retrospective national cohort study with exposed-unexposed design was conducted using the French National Health Data System.
settingThe exposed group included AYAs who underwent cancer treatment in France between 2012 and 2014 and was matched in a 1:1 ratio with the unexposed group of AYAs without cancer or chronic disease.
participantsA total of 7312 AYAs initiated cancer treatment during the specified period. After applying exclusion criteria, 3663 AYAs were matched to unexposed AYAs. PRIMARY AND SECONDARY OUTCOMES MEASURES: The primary outcome was compliance with gynaecological follow-up recommendations, including gynaecological consultation, sexually transmitted infections screening and cervical cancer screening. Secondary outcomes involved assessing each component of the follow-up, along with human papillomavirus vaccination coverage.
resultsExposed AYAs were significantly more likely to comply with gynaecological follow-up guidelines, with a compliance rate of 23.2%, compared with 16.5% among unexposed AYAs (OR 1.53, 95% CI 1.36 to 1.70; p<0.001). When each component of the primary outcome was analysed separately, compliance rates remained significantly higher among those exposed than among those unexposed AYAs. Regarding human papillomavirus vaccination, exposed AYAs displayed higher coverage, with a significantly greater proportion having initiated a catch-up schedule (28.1% vs 18.5%).
conclusionAYA cancer survivors were more likely to have gynaecological follow-up compliant with recommendations, including gynaecological consultations, sexually transmitted infections and cervical cancer screenings.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.